INSMED INC Unrealized Gain (Loss) on Investments
INSMED INC (INSM) reported Unrealized Gain (Loss) on Investments of -$450.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2015-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2015-02-27
- INSMED INC unrealized gain (loss) on investments for the quarter ending 2012-12-31 was -$835.00K, a 225.56% decline year-over-year.
- INSMED INC unrealized gain (loss) on investments for the quarter ending 2012-09-30 was $199.00K.
- INSMED INC unrealized gain (loss) on investments for the quarter ending 2012-06-30 was -$30.00K, a 109.90% decline year-over-year.
- INSMED INC unrealized gain (loss) on investments for the quarter ending 2012-03-31 was $216.00K.
- INSMED INC unrealized gain (loss) on investments for fiscal 2012 was -$450.00K, a 182.87% decline from fiscal 2011.
- INSMED INC unrealized gain (loss) on investments for fiscal 2011 was $543.00K.
- INSMED INC unrealized gain (loss) on investments for fiscal 2010 was -$548.00K, a 223.15% decline from fiscal 2009.
- INSMED INC unrealized gain (loss) on investments for fiscal 2009 was $445.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2012-12-31 | -$835.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$636.00K derived: sum of 2 quarters · filed 2015-02-27 | -$666.00K derived: sum of 3 quarters · filed 2015-02-27 | -$450.00K 10-K · filed 2015-02-27 | $450.00K 10-K · filed 2013-03-18 |
| 2012-09-30 | $199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $169.00K derived: sum of 2 quarters · filed 2013-11-05 | $385.00K 10-Q · filed 2013-11-05 | $1.05M derived: sum of 4 quarters · filed 2014-03-06 | |
| 2012-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $186.00K 10-Q · filed 2013-08-06 | $851.00K derived: sum of 3 quarters · filed 2014-03-06 | $605.00K derived: sum of 4 quarters · filed 2014-03-06 | |
| 2012-03-31 | $216.00K 10-Q · filed 2013-05-07 | $881.00K derived: sum of 2 quarters · filed 2014-03-06 | $635.00K derived: sum of 3 quarters · filed 2014-03-06 | $938.00K derived: sum of 4 quarters · filed 2014-03-06 | |
| 2011-12-31 | $665.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $419.00K derived: sum of 2 quarters · filed 2014-03-06 | $722.00K derived: sum of 3 quarters · filed 2014-03-06 | $543.00K 10-K · filed 2014-03-06 | -$543.00K 10-K · filed 2012-03-13 |
| 2011-09-30 | -$246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $57.00K derived: sum of 2 quarters · filed 2012-11-07 | -$122.00K 10-Q · filed 2012-11-07 | -$1.82M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $124.00K 10-Q · filed 2012-08-07 | -$1.57M derived: sum of 3 quarters · filed 2013-03-18 | -$1.03M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | -$179.00K 10-Q · filed 2012-05-08 | -$1.87M derived: sum of 2 quarters · filed 2013-03-18 | -$1.33M derived: sum of 3 quarters · filed 2013-03-18 | ||
| 2010-12-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$1.15M derived: sum of 2 quarters · filed 2013-03-18 | -$548.00K 10-K · filed 2013-03-18 | $548.00K 10-K · filed 2012-03-13 | |
| 2010-09-30 | $544.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | $1.15M 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | $602.00K 10-Q/A · filed 2011-08-08 | ||||
| 2009-12-31 | $445.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |